Search Results 1491-1500 of 20036 for Hepatitis b

1. Abatacept in Immune Checkpoint Inhibitor Myocarditis (ATRIUM) - Mayo Clinic

   These may include hepatitis B virus (HBV) or hepatitis C virus (HCV), recurrent or disseminated (even a single episode) herpes zoster, and disseminated ...

2. Emricasan, A Caspase Inhibitor, For Evaluation In Subjects With Non-Alcoholic Steatohepatitis (NASH) Fibrosis - Mayo Clinic

   Hepatitis and fibrosis more likely related to etiologies other than NASH such as. Alcoholic steatohepatitis; Autoimmune hepatitis; Hepatitis B virus (HBV) ...

3. Study Evaluating the Efficacy and Safety of Obeticholic Acid in Subjects With Compensated Cirrhosis Due to Nonalcoholic Steatohepatitis - Mayo Clinic

   Positive test result at Screening for hepatitis B surface antigen;; Active hepatitis C virus (HCV) infection (positive for HCV ribonucleic acid [RNA] at ...

4. Study of REGN2810 (Anti-PD-1) in Patients With Advanced Malignancies - Mayo Clinic

   ... hepatitis B or hepatitis C virus, except for designated cohorts that allow hepatitis or HIV (Patients with hepatitis B on antiviral therapy or patients with ...

5. Safety Study of Nivolumab With Nab-Paclitaxel Plus or Minus Gemcitabine in Pancreatic Cancer, Nab-Paclitaxel / Carboplatin in Stage IIIB/IV Non-Small Cell Lung Cancer or Nab-Paclitaxel in Recurrent Metastatic Breast Cancer - Mayo Clinic

   Subject has historical or active infection with hepatitis B, or hepatitis C. Subject is pregnant or breast-feeding. Subject is currently enrolled in any ...

6. ARTEMIS - A Research Study To Look At How Ziltivekimab Works Compared To Placebo In People With A Heart Attack - Mayo Clinic

   ... b) Electrocardiogram (ECG)-changes (in the absence of left ventricular ... -Known (acute or chronic) hepatitis B or hepatitis C -History or evidence of ...

7. A Study of MCLA-128 in Patients with Solid Tumors Harboring an NRG1 Fusion - Mayo Clinic

   active Hepatitis B infection (HBsAg positive) without receiving antiviral treatment; Note: Patients with active hepatitis B (HBsAg positive) must receive ...

8. Trial Of Neoadjuvant Enoblituzumab Vs SOC In Men With High-Risk Localized Prostate Cancer - Mayo Clinic

   ... hepatitis B/C, with the exception of patients who have been successfully treated for hepatitis B/C (i.e. documented confirmation of cure at least 6 months ...

9. Anetumab Ravtansine and Atezolizumab in Treating Participants With Advanced Non-small Cell Lung Cancer - Mayo Clinic

   ... B surface antigen [HBsAg] test and a positive anti-HBc [antibody to hepatitis B core antigen] antibody test) are eligible;; Patients positive for hepatitis C ...

10. Study to Evaluate the Safety and Effectiveness of BMS-986036 in Adults with Nonalcoholic Steatophepatitis (NASH) and Stage 3 Liver Fibrosis - Mayo Clinic

    Other causes of liver disease (e.g., alcoholic liver disease, hepatitis B virus infection, chronic hepatitis C virus infection (see Appendix 3), autoimmune ...